ATC tend to accumulate multiple mutations in genes readily present in DTC like BRAF or RAS, or kinase fusion-related thyroid carcinomas (NTRK, RET or ALK), in addition to higher risk genes like TERT promoter, TP53, PIK3CA and PTEN [91,92]. The gene discussed is ALK; the disease is thyroid gland carcinoma.